HCM
ABBV icon

Hamlin Capital Management’s AbbVie ABBV Stock Holding History

Hamlin Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186M Sell
738,590
-97,876
-12% -$21.1M 4.18% 7
2026
Q1 		$182M Sell
836,466
-98,718
-11% -$21.9M 4.39% 9
2025
Q4 		$214M Sell
935,184
-126,855
-12% -$28.9M 5.12% 5
2025
Q3 		$246M Sell
1,062,039
-3,124
-0.3% -$636K 5.6% 2
2025
Q2 		$198M Buy
1,065,163
+9,757
+0.9% +$1.81M 4.58% 8
2025
Q1 		$221M Buy
1,055,406
+13,267
+1% +$2.58M 5.29% 1
2024
Q4 		$185M Buy
1,042,139
+18,108
+2% +$3.33M 4.59% 5
2024
Q3 		$202M Buy
1,024,031
+76,218
+8% +$14.2M 5.08% 3
2024
Q2 		$163M Sell
947,813
-2,226
-0.2% -$369K 4.79% 3
2024
Q1 		$173M Sell
950,039
-6,658
-0.7% -$1.15M 5.11% 2
2023
Q4 		$148M Sell
956,697
-4,673
-0.5% -$681K 4.67% 4
2023
Q3 		$143M Buy
961,370
+9,251
+1% +$1.36M 4.93% 3
2023
Q2 		$128M Buy
952,119
+1,791
+0.2% +$263K 4.3% 9
2023
Q1 		$151M Sell
950,328
-19,302
-2% -$2.95M 5.28% 2
2022
Q4 		$157M Buy
969,630
+22,373
+2% +$3.43M 5.57% 2
2022
Q3 		$127M Buy
947,257
+77
+0% +$11K 5.08% 3
2022
Q2 		$145M Buy
947,180
+13,613
+1% +$2.08M 5.82% 1
2022
Q1 		$151M Sell
933,567
-12,022
-1% -$1.75M 5.34% 1
2021
Q4 		$128M Buy
945,589
+10,245
+1% +$1.21M 4.54% 2
2021
Q3 		$101M Sell
935,344
-1,275
-0.1% -$146K 4.02% 8
2021
Q2 		$106M Buy
936,619
+39,155
+4% +$4.41M 4.16% 4
2021
Q1 		$97.1M Buy
897,464
+5,343
+0.6% +$572K 3.98% 8
2020
Q4 		$95.6M Buy
892,121
+28,253
+3% +$2.72M 4.41% 3
2020
Q3 		$75.7M Buy
863,868
+177,344
+26% +$16.7M 4% 9
2020
Q2 		$67.4M Sell
686,524
-188,032
-22% -$16.6M 3.6% 5
2020
Q1 		$66.6M Sell
874,556
-84,328
-9% -$7.18M 3.99% 5
2019
Q4 		$84.9M Sell
958,884
-6,214
-0.6% -$516K 3.53% 7
2019
Q3 		$73.1M Buy
965,098
+156,975
+19% +$10.8M 3.29% 14
2019
Q2 		$58.8M Buy
808,123
+101,883
+14% +$8.01M 2.52% 20
2019
Q1 		$56.9M Sell
706,240
-20,465
-3% -$1.67M 2.54% 18
2018
Q4 		$67M Buy
726,705
+8,976
+1% +$789K 3.12% 15
2018
Q3 		$67.9M Buy
717,729
+131,581
+22% +$12.5M 2.66% 22
2018
Q2 		$54.3M Sell
586,148
-19,665
-3% -$1.92M 2.21% 29
2018
Q1 		$57.3M Sell
605,813
-170,498
-22% -$18.7M 2.22% 23
2017
Q4 		$75.1M Sell
776,311
-25,904
-3% -$2.44M 2.88% 19
2017
Q3 		$71.3M Sell
802,215
-432,580
-35% -$32.9M 2.89% 20
2017
Q2 		$89.5M Sell
1,234,795
-10,071
-0.8% -$677K 3.74% 7
2017
Q1 		$81.1M Buy
1,244,866
+158,763
+15% +$9.98M 3.43% 8
2016
Q4 		$68M Buy
1,086,103
+95,911
+10% +$5.85M 3.04% 10
2016
Q3 		$62.5M Sell
990,192
-19,589
-2% -$1.27M 2.89% 12
2016
Q2 		$62.5M Buy
1,009,781
+9,391
+0.9% +$572K 3.03% 17
2016
Q1 		$57.1M Sell
1,000,390
-39,278
-4% -$2.19M 2.89% 22
2015
Q4 		$61.6M Buy
1,039,668
+297,585
+40% +$17.1M 3.33% 12
2015
Q3 		$40.4M Sell
742,083
-394,625
-35% -$25.7M 2.23% 28
2015
Q2 		$76.4M Buy
1,136,708
+23,820
+2% +$1.56M 3.85% 4
2015
Q1 		$65.1M Buy
1,112,888
+392,773
+55% +$23.7M 3.43% 6
2014
Q4 		$47.1M Buy
720,115
+12,094
+2% +$762K 2.63% 20
2014
Q3 		$40.9M Buy
708,021
+15,645
+2% +$869K 2.45% 23
2014
Q2 		$39.1M Sell
692,376
-312,693
-31% -$16.4M 2.2% 28
2014
Q1 		$51.7M Buy
1,005,069
+21,635
+2% +$1.09M 3.32% 9
2013
Q4 		$51.9M Buy
983,434
+7,498
+0.8% +$369K 3.53% 5
2013
Q3 		$43.7M Buy
975,936
+24,000
+3% +$1.06M 3.26% 10
2013
Q2 		$39.4M Buy
+951,936
New +$41.6M 3.21% 9

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Hamlin Capital Management's ABBV Position: Q2 2026 in Review

Hamlin Capital Management reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $21.1M and leaving 738,590 shares worth $186M. The position accounts for 4.18% of the portfolio, ranked #7.

Hamlin Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $246M in Q3 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hamlin Capital Management held 738,590 shares of AbbVie worth $186M as of Q2 2026.
  • Hamlin Capital Management sold 97,876 AbbVie shares in Q2 2026, an estimated $21.1M.
  • AbbVie made up 4.18% of Hamlin Capital Management's portfolio in Q2 2026, its #7 holding.
  • Hamlin Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Hamlin Capital Management's AbbVie position peaked at $246M in Q3 2025.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hamlin Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.